AbbVie Inc. Company Information

AbbVie Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: AbbVie Inc.
  • Ticker: 4AB
  • Exchange: BUL
  • Founded: 2012
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$317.096b
  • Listing Market Cap: US$308.312b
  • Shares Outstanding: 1.77b
  • Website: https://www.abbvie.com

Number of Employees


Location

  • AbbVie Inc.
  • 1 North Waukegan Road
  • North Chicago
  • Illinois
  • 60064-6400
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ABBV *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNDec 2012
ABBVNYSE (New York Stock Exchange)YesCommon StockUSUSDDec 2012
4ABDB (Deutsche Boerse AG)YesCommon StockDEEURDec 2012
0QCVLSE (London Stock Exchange)YesCommon StockGBUSDDec 2012
ABBVWBAG (Wiener Boerse AG)YesCommon StockATEURDec 2012
4ABXTRA (XETRA Trading Platform)YesCommon StockDEEURDec 2012
4ABBVETLX (Eurotlx)YesCommon StockITEURDec 2012
4ABBUL (Bulgaria Stock Exchange)YesCommon StockBGEURDec 2012
4ABDBATS-CHIXE (BATS 'Chi-X Europe')YesCommon StockGBEURDec 2012
ABBVBVL (Bolsa de Valores de Lima)YesCommon StockPEUSDDec 2012
ABBVCLSNSE (Santiago Stock Exchange)YesCommon StockCLCLPDec 2012
ABBV34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 16 REPR 1 COMBRBRLApr 2016
ABBVDBASE (Buenos Aires Stock Exchange)CEDEAR EA 10 REP 1 COM(USD)ARUSDMar 2021
ABBVBASE (Buenos Aires Stock Exchange)CEDEAR EA 10 REP 1 COM(USD)ARARSMar 2021
ABBVNEOE (Aequitas Neo Exchange)Cdr Cad Hedged Reg SCACADNov 2022
4AB0DB (Deutsche Boerse AG)Cdr Cad Hedged Reg SDEEURNov 2022

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2025/01/03 21:02
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 21:02
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AbbVie Inc. is covered by 54 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Luisa HectorBerenberg